Why share volume of tiny biotech Celator is surpassing that of Apple
March 15, 2016 at 13:37 PM EDT
Investors are more interested in what may be the newest way in more than 40 years to better treat a type of deadly blood cancer than they are the next iteration of Apple Inc.’s iPhone.
